News
Axsome Therapeutics (NASDAQ:AXSM) is increasingly poised to become the single most important player in the Major Depressive Disorder space, with its Auvelity tracking ahead...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced equities with...
News
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As...
News
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded...
News
By Daniel Chu, CFA, Charles Hamieh, Shane Hurst, & Nick Langley Infrastructure Valuations Attractive Despite Consensus Narrative Market Overview General equities as well as...
News
Investment Thesis iRobot Corporation (NASDAQ:IRBT), known for its Roomba vacuum cleaners, finds itself at a financial crossroads. iRobot Corporation, despite its 30-year history and...
News
NexPoint Residential Trust (NYSE:NXRT) has been rocked by rising interest rates with the common shares down 29% year-to-date to trade at its lowest level...
News
Celestica (NYSE:CLS) showcased a commendable financial performance in Q2 2023, registering a notable surge in revenue compared to Q2 2022. This upward trend was...
News
Introduction It is time to summarize another quarter. The third quarter of 2023 saw the S&P 500 down 4% following a powerful Q2. September...
News
I have been increasingly critical in my writings this year of the overwhelmingly negative take on just about everything related to the economy and...
News
Insurance is vital for gig workers because they lack consistent employer-provided benefits. The gig economy refers to a labor market characterized by the prevalence...
News
Shares of CrowdStrike Holdings (NASDAQ:CRWD) have seen a strong revaluation since December 2022 which is when I last worked on the cybersecurity company. CrowdStrike...
News
Gilead Sciences (NASDAQ:GILD) is a $95-billion market cap biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and selling treatments for...
